Senior insider sale
Chief Medical Officer at DEFINIUM THERAPEUTICS, INC. — senior position signals high conviction
$53.4K
7.85K shares
What this filing means
KARLIN DANIEL plans to sell 7.85K shares of DEFINIUM THERAPEUTICS, INC. valued at approximately $53.4K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 6/25/2025ACC: 0001950047-25-004604
Officer· Chief Medical Officer
Since Jan 2022
7.85K
Shares to sell
$53.4K
Approx. market value
7.85K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Restricted stock vesting under a registered plan
Compensation
6/25/2025
7.85KTotal acquired7.85K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
6/25/2025 | Restricted stock vesting under a registered plan Compensation | 7.85K | — |
| Total | 7.85K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
7.85K
Market value
$53.4K
6/25/2025
Total
Units
7.85K
Value
$53.4K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
6/25/2025 | 7.85K | $53.4K | NASDAQ | Planned |
| Total | 7.85K | $53.4K | ||